DEVELOPMENT OF RESISTANCE TO QUINOLONES IN 5 PATIENTS WITH CAMPYLOBACTERIOSIS TREATED WITH NORFLOXACIN OR CIPROFLOXACIN

被引:47
作者
ADLERMOSCA, H
LUTHYHOTTENSTEIN, J
LUCCHINI, GM
BURNENS, A
ALTWEGG, M
机构
[1] UNIV ZURICH,DEPT MED MICROBIOL,GLORIASTR 32,CH-8028 ZURICH,SWITZERLAND
[2] UNIV BERN,INST VET BACTERIOL,CH-3012 BERN,SWITZERLAND
关键词
D O I
10.1007/BF02005451
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Development of resistance to nalidixic acid, norfloxacin and ciprofloxacin was observed in five patients with Campylobacter jejuni or Campylobacter coli infection. From all these patients nalidixic acid- and quinolone-susceptible strains were isolated initially, whereas after therapy with norfloxacin or ciprofloxacin strains resistant to these antibiotics were found. Campylobacter strains from the same patient always belonged to the same species and, with the exception of one case, showed identical rRNA gene restriction (rDNA) patterns. This indicates that double-infection with a susceptible and a resistant strain was not responsible for the phenomenon but rather that the infecting strain rapidly developed resistance following treatment.
引用
收藏
页码:953 / 956
页数:4
相关论文
共 19 条
[1]   PROBLEMS IN IDENTIFICATION OF CAMPYLOBACTER-JEJUNI ASSOCIATED WITH ACQUISITION OF RESISTANCE TO NALIDIXIC-ACID [J].
ALTWEGG, M ;
BURNENS, A ;
ZOLLINGERITEN, J ;
PENNER, JL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (09) :1807-1808
[2]  
ANSUBEL FM, 1989, CURRENT PROTOCOLS MO
[3]   DIARRHEA AND CAMPYLOBACTER INFECTIONS IN PATIENTS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS [J].
BERNARD, E ;
ROGER, PM ;
CARLES, D ;
BONALDI, V ;
FOURNIER, JP ;
DELLAMONICA, P .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) :143-144
[4]   FLUOROQUINOLONE RESISTANCE IN CAMPYLOBACTER SPP ISOLATED FROM HUMAN STOOLS AND POULTRY PRODUCTS [J].
ENDTZ, HP ;
MOUTON, RP ;
VANDERREYDEN, T ;
RUIJS, GJ ;
BIEVER, M ;
VANKLINGEREN, B .
LANCET, 1990, 335 (8692) :787-787
[5]   EMPIRIC ANTIMICROBIAL THERAPY OF DOMESTICALLY ACQUIRED ACUTE DIARRHEA IN URBAN ADULTS [J].
GOODMAN, LJ ;
TRENHOLME, GM ;
KAPLAN, RL ;
SEGRETI, J ;
HINES, D ;
PETRAK, R ;
NELSON, JA ;
MAYER, KW ;
LANDAU, W ;
PARKHURST, GW ;
LEVIN, S .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (03) :541-546
[6]   COMPARATIVE INVITRO ACTIVITIES OF AZTREONAM, CIPROFLOXACIN, NORFLOXACIN, OFLOXACIN, HR-810 (A NEW CEPHALOSPORIN), RU28965 (A NEW MACROLIDE), AND OTHER AGENTS AGAINST ENTEROPATHOGENS [J].
GOOSSENS, H ;
DEMOL, P ;
COIGNAU, H ;
LEVY, J ;
GRADOS, O ;
GHYSELS, G ;
INNOCENT, H ;
BUTZLER, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :388-392
[7]   A NEW SELECTIVE MEDIUM FOR THE ISOLATION OF CAMPYLOBACTER-JEJUNI FROM HUMAN FECES [J].
GOOSSENS, H ;
DEBOECK, M ;
BUTZLER, JP .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (04) :389-393
[8]   INVITRO SUSCEPTIBILITY OF CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI ISOLATED IN AUSTRIA TO ERYTHROMYCIN AND CIPROFLOXACIN [J].
HIRSCHL, AM ;
WOLF, D ;
BERGER, J ;
ROTTER, ML .
ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES, 1990, 272 (04) :443-447
[9]   SUSCEPTIBILITY OF CLINICAL ISOLATES OF CAMPYLOBACTER-JEJUNI TO 25 ANTIMICROBIAL AGENTS [J].
LARIVIERE, LA ;
GAUDREAU, CL ;
TURGEON, FF .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (06) :681-685
[10]   MIXED INFECTIONS WITH DIFFERENT SPECIES AND SEROTYPES OF CAMPYLOBACTER [J].
LASTOVICA, AJ ;
LEROUX, E ;
PENNER, JL .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (02) :375-375